Pain Relief

Pain Relief

Cannabinoids affects on Pain Relief from chronic pain

Enjoy these links to studies and research on cannabis and various medical condition. Supplementation with cannabinoids will have different effects for each person, we are not medically trained or qualified to give medical advice. We do not suggest that cannabis will treat, cure or prevent any particular medical condition, we merely present these links and research to aid your further investigation.  The majority of these studies are conducted under strict supervision with high doses.

More and more people are seeking pain relief from a host of conditions – from severe sciatica or multiple sclerosis to arthritis, migraines, and irritable bowel syndrome amongst others. The well-established painkillers of opioids and NSAIDs are known to be addictive and cause a huge numbers of deaths worldwide every year. Cannabidiol (CBD) on the other hand works in harmony with the body’s endocannabinoid system to relieve pain – read more about your endocannabinoid system here. CBD is not addictive and throughout its long history of being used for pain relief has not resulted in any fatalities.

We will be researching various conditions in greater depth so sign up as a NuFriend to keep up to date with our free resources.

Link: Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis

A study that examined efficacy of transdermal CBD for reduction in inflammation and pain, assessing any adverse effects in a rat complete Freund’s adjuvant-induced monoarthritic knee joint model.

Link: Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine.

Report on new information on the effects on sleep in the context of medical treatment of neuropathic pain and symptoms of multiple sclerosis, employing standardised oromucosal cannabis-based medicines containing primarily THC, CBD, or a 1 : 1 combination of the two (Sativex).

Link: Cannabinoids for neuropathic pain.

This article reviews the history, pharmacologic development, clinical trials results, and the future potential of nonsmoked, orally bioavailable, nonpsychoactive cannabinoids in the management of neuropathic pain.


Leave a reply